Navigation Links
China Sky One Medical Receives Medical Industry Awards
Date:1/27/2011

HARBIN, China, Jan. 27, 2011 /PRNewswire-Asia/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced that Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong"), the Company's wholly owned operating subsidiary, was named a "Top Ten Branded Company Trusted by Consumers" according to research and rankings conducted jointly by influential and authoritative institutions including, China Medical Association, China Pharmaceutical Association, China Medical Brand Research Association, and the Brand Research Center of Business Times Newspaper. The designation is based on product quality and brand recognition among domestic Chinese pharmaceutical companies. Additionally, China Sky One's "Yu Fu" branded Compound Camphor Cream was named a "Top Ten Brand for Skin Treatment Medicine" and Mr. Yan-qing Liu, the Company's Chairman and CEO, was elected as a "Top Ten Trusted Entrepreneur in China's Medical Industry." Please click here to view certificates of these awards.

(Photo:  http://photos.prnewswire.com/prnh/20110127/CN37464 )

"We are honored to receive these awards and appreciate the ongoing support of our loyal customers. Entering 2011, we will strive to maintain the highest product quality standards and introduce more innovative new products to address the needs of China's large and growing health care market," said Mr. Yan-Qing Liu, Chairman and CEO of China Sky One Medical.

About China Sky One Medical, Inc. China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company, Harbin First Bio-Engineering Company Limited, Heilongjiang Tianlong Pharmaceutical, Inc. and Peng Lai Jin Chuang Pharmaceutical Company, the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.cski.com.cn.

Safe Harbor Statement

Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding the Company's brand recognition and product quality. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.Investor Relations Contact:China Sky One Medical

CCG Investor RelationsYanqing Liu, CEO

Crocker Coulson, PresidentEmail: ir@cski.com.cn

Tel: +1-646-213-1915Email: crocker.coulson@ccgir.comWebsite: www.ccgirasia.com Mabel Zhang, Vice PresidentTel: +1-310-954-1353Email: mabel.zhang@ccgir.com
'/>"/>

SOURCE China Sky One Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston Scientific Begins Clinical Trial Enrollment in China for PROMUS Element™ Everolimus-Eluting Stent
2. Reportlinker Adds The Top 10 CMOs in China
3. Shareholder Letter from Chairman of China Sky One Medical
4. Wolters Kluwer Health Enters Joint Venture with China Drug Information Provider Medicom
5. Reportlinker Adds 2010-2015 In-depth Research Report on China Sodium Fluoride Industry
6. Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China
7. Topical China Industries Research Reports Published at MarketPublishers.com
8. China Botanic Announces Progress on its SOX 404 Compliance Program
9. China Botanic Appoints David Dong as New Chief Financial Officer
10. Food and Drug Law Institute to Hold Historic Conference on U.S.-China Food and Drug Law
11. China Botanic Achieves Three Million RMB Sales of New Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... 11, 2016  Kindred Biosciences, Inc. (NASDAQ: KIN ... the lives of pets, today announced the submission to ... Animal Drug Application (NADA) for Zimeta™ (dipyrone injection, KIND-012).  ... of Zimeta for the control of pyrexia (fever) in ... --> --> The Chemistry, Manufacturing, ...
(Date:2/11/2016)... FRANCISCO , Feb. 11, 2016   Health ... advancement of new health technologies, announced today " 10 ... achievements in health tech over the past ten years.   ... For nearly a decade, Health 2.0 has served as ... showcased and connected with thousands of technologies, companies, innovators, ...
(Date:2/11/2016)... Feb. 11, 2016  MiMedx Group, Inc. (NASDAQ: ... amniotic membrane and other birth tissues, human skin and ... and market advanced products and therapies, announced today that ... Global Healthcare Conference in New York ... Michael J. Senken , Chief Financial Officer and ...
Breaking Medicine Technology:
(Date:2/12/2016)... York, NY (PRWEB) , ... February 12, 2016 ... ... edition of “Revolutionizing Cancer Care.” , The print component of “Revolutionizing ... Chicago, Dallas, Pittsburgh/Cleveland, New York, Washington DC/Baltimore, and Seattle, with a circulation of ...
(Date:2/12/2016)... ... February 12, 2016 , ... Atlantic Information Services, Inc. ... and PBMs,” an upcoming Feb. 24 webinar that will discuss ways health plans ... categories, such as the $1,000-per-pill hepatitis C treatment Sovaldi and high-cost PCSK9 inhibitors ...
(Date:2/12/2016)... ... ... US Sport Camps is pleased to announce the addition of junior golf ... the host site and directing the camps is PGA Professional and 2008 Iowa State ... recent years around Des Moines and are fortunate to have such a well-respected instructor ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Healthcare careers ... the five most searched jobs via the website of healthcare staffing leader Aureus Medical ... travel nurse jobs , travel therapy positions and in travel and ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... growth in the field of long term care. With that, says Patrick Loughney, ... healthcare professionals in administrative roles in long term care environments. His company, which ...
Breaking Medicine News(10 mins):